Rising Pharmaceuticals, Inc. FDA Inspection Record

FEI 3004813192 · Inspections, Form 483s, warning letters and import refusals

Rising Pharmaceuticals, Inc. is an FDA-inspected facility (FEI 3004813192) located in Saddle Brook, NJ, US. RegDataLab tracks 3 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Jan 28, 2019: Voluntary Action Indicated (VAI)
Inspections on record
3 (1 VAI, 2 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
3, latest Nov 15, 2019
Import refusals
1

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Jan 28, 2019Voluntary Action Indicated (VAI)Late submission of quarterly safety reports (21 CFR 314.80(c)(2))
Jan 16, 2019No Action Indicated (NAI)No citations listed
Sep 16, 2013No Action Indicated (NAI)Specifications - labels, packaging (21 CFR 111.70(d))
Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
Component - certificate of analysis (21 CFR 111.75(a)(2)(ii)(B))

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Nov 15, 2019Class IIID-1367-2020Timolol Maleate USP, 0.5%, 5 mL, Sterile Opthalmic Solution, Rx Only, For Topical… and 1 more product
Labeling: Label mix-up: A case of Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml, had the outer carton for Timolol Maleate…
Mar 7, 2019Class IID-1052-2019Valsartan Tablets 40 mg USP, 30 tablet bottles, Rx, Only, Distributed by: Acetris Health… and 3 more products
CGMP Deviations; Detection of a trace amount of unexpected impurity N- nitrosodiethylamine (NDEA) found in finished products
Jul 7, 2005Class IIID-441-5Renaphro Softgels, Each softgel contains: Vitamin C 100mg, Folic Acid 1mg, Niacinamide…
Subpotent; calcium pantothenate

FDA record score

3 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

2 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAIJan 28, 20196 x 0.251.5
Class II recall D-1052-2019, this FEI as the recalling firmMar 7, 20194 x 0.251

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 16, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 16, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 16, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 16, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Rising Pharmaceuticals, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Rising Pharmaceuticals, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Rising Pharmaceuticals, Inc.
Location
Saddle Brook, NJ (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.